| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2ec8ee5a2eb45c0f84227452678497a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c09a7eda6e886f18e2659de67222189e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fd0459b1b0322dad7c35e1343fa5911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fbbf7764331fc0bb4fcec2ed8664a0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71bbb145743dc0213c302a45d759ba3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95cbcbcd9201f5f08be007a361f1c86a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2286cc77c7cd5196dc593c0427c09651 |
| publicationDate |
2022-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022122938-A1 |
| titleOfInvention |
Hormad1 therapeutics |
| abstract |
The present invention relates to the treatment of cancer and, in particular to the treatment of patients whose cancer expresses HORMAD1 with an agent that modulates mitotic processes, and diagnostic methods thereof. |
| priorityDate |
2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |